BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2896286)

  • 1. The benzodiazepine receptor inverse agonists beta-CCM and RO 15-3505 both reverse the anxiolytic effects of ethanol in mice.
    Belzung C; Misslin R; Vogel E
    Life Sci; 1988; 42(18):1765-72. PubMed ID: 2896286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine antagonist RO 15-1788 partly reverses some anxiolytic effects of ethanol in the mouse.
    Belzung C; Vogel E; Misslin R
    Psychopharmacology (Berl); 1988; 95(4):516-9. PubMed ID: 2905501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic and non-anxiogenic benzodiazepine antagonists.
    Prado de Carvalho LP; Grecksch G; Chapouthier G; Rossier J
    Nature; 1983 Jan; 301(5895):64-6. PubMed ID: 6296684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline.
    Prado de Carvalho L; Venault P; Cavalheiro E; Kaijima M; Valin A; Dodd RH; Potier P; Rossier J; Chapouthier G
    Adv Biochem Psychopharmacol; 1983; 38():175-87. PubMed ID: 6142602
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of the intoxicating effects of ethanol by drugs acting at the benzodiazepine-GABA receptor complex.
    Durcan MJ; Lister RG
    Pharmacol Biochem Behav; 1989 Mar; 32(3):667-70. PubMed ID: 2544902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does RO 15-4513 reverse the anxiolytic effects of ethanol by its intrinsic properties?
    Belzung C; Misslin R; Vogel E
    Pharmacol Biochem Behav; 1988 Aug; 30(4):867-70. PubMed ID: 2906436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone.
    Polc P; Bonetti EP; Schaffner R; Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):260-4. PubMed ID: 6132340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiogenic effects of a benzodiazepine receptor partial inverse agonist, RO 19-4603, in a light/dark choice situation.
    Belzung C; Misslin R; Vogel E
    Pharmacol Biochem Behav; 1990 Jul; 36(3):593-6. PubMed ID: 2165618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse.
    Crawley JN; Skolnick P; Paul SM
    Neuropharmacology; 1984 May; 23(5):531-7. PubMed ID: 6146107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing the anticonvulsant effect of ethanol using drugs acting at the benzodiazepine/GABA receptor complex.
    Nutt DJ; Lister RG
    Pharmacol Biochem Behav; 1988 Nov; 31(3):751-5. PubMed ID: 2855119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety.
    Lister RG
    Pharmacol Biochem Behav; 1988 Jul; 30(3):701-6. PubMed ID: 3211980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.
    Belzung C; Misslin R; Vogel E
    Psychopharmacology (Berl); 1989; 97(3):388-91. PubMed ID: 2566186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benzodiazepine receptor ligand, methyl beta-carboline-3-carboxylate, is both sedative and proconvulsant in chicks.
    Venault P; Prado de Carvalho L; Brown CL; Dodd RH; Rossier J; Chapouthier G
    Life Sci; 1986 Sep; 39(12):1093-100. PubMed ID: 3018410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of benzodiazepine and beta-carboline inverse agonists on body temperature in mice.
    Jackson HC; Nutt DJ
    Eur J Pharmacol; 1991 Nov; 205(2):213-6. PubMed ID: 1812012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral interactions between ethanol and imidazodiazepines with high affinities for benzodiazepine receptors.
    Lister RG
    Life Sci; 1988; 42(14):1385-93. PubMed ID: 2832675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of flumazenil, Ro 15-4513 and beta-CCM on the behaviour of control and stressed mice in the plus-maze test.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1997 Jun; 48(2):253-61. PubMed ID: 9223029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.
    Pellow S; File SE
    J Pharm Pharmacol; 1985 Aug; 37(8):560-3. PubMed ID: 2864417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-regulation of ICSS duration: effects of anxiogenic substances, benzodiazepine antagonists and antidepressants.
    Gerhardt S; Liebman JM
    Pharmacol Biochem Behav; 1985 Jan; 22(1):71-6. PubMed ID: 2858109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.
    Belzung C; Misslin R; Vogel E; Dodd RH; Chapouthier G
    Pharmacol Biochem Behav; 1987 Sep; 28(1):29-33. PubMed ID: 3116561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.